Search

everythinglearnresearchcommunity

for

Search:↓

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

lncRNAs are important for understanding and treating skin diseases.

miR-200c-3p could help diagnose and treat alopecia areata.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

ALRN-6924 may prevent hair loss caused by chemotherapy.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

PCOS is linked to low-grade chronic inflammation.

Anti-CD19 therapy may help treat SLE and NMOSD.

Oral Janus kinase inhibitors may be an effective treatment option for lichen planopilaris with some risk of increased cholesterol and liver enzyme levels.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

LRIG1 is linked to better survival in Merkel cell carcinoma.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Researchers found a new genetic mutation linked to a hair condition in a Japanese boy.